Fresh analysis reveals that individuals who discontinue blockbuster slimming jabs like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Research printed in a prominent medical journal points out that while overweight individuals frequently drop about a fifth of their total mass while on the medication, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"People buying these drugs need to be cognizant of the potential of quick rebound weight gain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight in about a year and a half.
Weighing Therapies
The study, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of the injectable medications with older methods.
Scientists emphasize that people who shed pounds through lifestyle changes alone generally have a more gradual weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Fast Regain
Doctors suggest the way of the jabs explains the amplified rebound.
These medications copy a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication leads to hunger is uncontrolled, making excessive eating much more probable."
A Lifelong Disease?
Medical guidelines advise the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts contend that, due to the likelihood of weight regain, the treatment is often life-long.
This opinion is supported by drug manufacturers, who note that the results "underscore the chronic character of excess weight," similar to managing conditions like high blood pressure.
Patient Experiences
Users who have discontinued the jabs describe a intense resurgence of cravings.
"I experienced something activating and you become ravenous," described an individual.
This difficulty is worsened if individuals have not adopted lasting lifestyle or habit modifications during treatment.
Widespread Use
Survey data indicate that a significant number of people in the UK have used these injections in the past year, with demand remaining high.
- Adoption is greater among women compared to men.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone solution and long-term success relies on ongoing lifestyle management.
